コラーゲンリモデリングによるCAF駆動メカニカル伝導は,腫瘍細胞サイクル進行を加速する
Yating Xiao1,2, Yingying Jiang1,2, Ting Bao3
1Institute of Biomedical Engineering and Health Sciences, Changzhou University, Changzhou 213164, China.
Gels (Basel, Switzerland)
|August 28, 2025
まとめ
癌に関連した線維細胞 (CAF) はコラーゲンゲルを硬化し,機械的なストレスによって乳がん細胞の増殖を促進します. これらのCAF媒介による変化をターゲットにすることで 癌治療の新たな戦略が生まれます
科学分野:
- 生物医学工学
- 癌 生物学
- 機械生物学
背景:
- 癌に関連した線維細胞 (CAF) は腫瘍の微小環境を再構成し,がんの進行に影響を与えます.
- 従来のヒドロゲルモデルは,細胞の行動に対する局所的な硬さの影響を理解するために不可欠な空間的異質性を捉えることができない.
研究 の 目的:
- 癌に関連したフィブロブラスト誘発のコラーゲンヒドロゲル改造が乳がん細胞増殖にどのように影響するか調査するための新しい微小組織プラットフォームを開発する.
- 局所的な硬度グラデーションががん細胞サイクル進行を調節する生体力学的メカニズムとシグナル伝達経路を解明する.
主な方法:
- 機械的な定量化のためのプログラム可能なマイクロストリングを備えたコラーゲンヒドロゲルマイクロ組織プラットフォームの開発.
- FUCCIの細胞サイクルバイオセンサと分子干渉を統合して,細胞サイクルとシグナリングを監視する.
- 凝固,硬度変化,毛穴の縮小をリアルタイムで測定する.
主要な成果:
- CAFの収縮により,ヒドロゲルの硬さ (350~775 Pa) が著しく増加し,毛穴の直径 (5.0~1. 9 μm) が減少した.
- コラーゲン-インテグリン-アクトミオシン信号伝達によるYAP/TAZ核転移が活性化され,癌細胞の増殖が2. 4倍に増加しました.
- YAP,アクトミオシン,またはコラーゲンの薬理学的阻害は,これらの効果を逆転させ,CYR61のノックダウン時に部分的な救済が観察されました.
結論:
- CAFによって改造されたコラーゲン水素は,腫瘍の成長の重要な生体力学的調節体として作用する.
- CAFを媒介するメカニカル伝達経路をターゲットにすることは,有望な抗がん治療戦略です.
関連する概念動画
Cell-matrix's Response to Mechanical Forces
2.7K
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue.
Anchoring junctions mechanically attach a cell to the...
Anchoring junctions mechanically attach a cell to the...
2.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tension Response at Adherens Junctions
2.8K
The adherens junctions that anchor cells together are multi-protein complexes that dynamically adapt to mechanical stimuli such as tensile forces and shear stress. Mechanosensory proteins in these junctions can sense such mechanical stimuli and undergo a shift in their conformation, resulting in an altered function — a process called mechanotransduction.
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
2.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


